N-acetylglutamate Synthase Deficiency
📧 Sign up to get email alerts when something new happens for N-acetylglutamate Synthase Deficiency.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-05-30FDA Approved: CARGLUMIC ACID — Supplemental Application (Eton Pharmaceuticals, Inc.)
The FDA approved a supplemental application for carglumic acid submitted by Eton Pharmaceuticals, Inc.
-
FDA approval · 2024-01-19FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
FDA approved a supplemental application for CARBAGLU (carbaglumic acid) submitted by Recordati Rare Diseases.
-
FDA approval · 2021-08-05FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
The FDA approved a supplemental application for CARBAGLU (carbaglumic acid) from Recordati Rare Diseases, extending its approved use for pat…
-
FDA approval · 2021-01-22FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
The FDA approved a supplemental application for CARBAGLU (carglumic acid) from Recordati Rare Diseases. The action pertains to a supplement …
-
FDA approval · 2019-12-23FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
The FDA approved a supplemental application for CARBAGLU (carbaglumic acid) submitted by Recordati Rare Diseases. The action represents an a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-11-16FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
The FDA approved a supplemental application for CARBAGLU (carglumic acid) from Recordati Rare Diseases, expanding its labeling for the treat…
-
FDA approval · 2014-01-23FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
The FDA approved a supplemental application for CARBAGLU (carbaglumic acid) submitted by Recordati Rare Diseases.
-
FDA approval · 2013-08-05FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
The FDA approved a supplemental application for CARBAGLU (carglumic acid) submitted by Recordati Rare Diseases.
-
FDA approval · 2013-07-22FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
The FDA approved a supplemental application for CARBAGLU (carbaglumic acid) submitted by Recordati Rare Diseases. This action authorizes cha…